Game-Changing Updates in the Management of Sickle Cell Disease
Featured
Game-Changing Updates in the Management of Sickle Cell DiseaseThe speakers and panelists discuss sickle cell disease, its prevalence, new gene therapy management strategies, and relevant ethical considerations. A pioneering CRISPR patient gives her perspective on undergoing gene-editing therapy and how that has impacted her health and quality of life.
CME & Ethics credit available